Effect of Intravenous Acetadote on Incidence of Contrast Induced Nephropathy

NCT00939913 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Nephropathy

Interventions

DRUG: intravenous NAC
DRUG: Placebo

Sponsor

Ochsner Health System

Collaborators

[object Object]